Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Subviral Agents01:29

Subviral Agents

583
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
583
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

919
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
919
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

1.3K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.3K
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

1.8K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.8K
Air-entraining Agents01:27

Air-entraining Agents

276
Air-entraining agents improve the durability and workability of concrete in climates with frequent freezing and thawing. These agents prevent cracks by introducing small air bubbles into the mix, creating spaces accommodating water expansion when temperatures drop. The air-entraining agents lower the surface tension of water, forming stable, small air bubbles. This method is more effective than having accidental large voids, as the intentional, smaller, and evenly distributed air voids improve...
276

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is Transcatheter Aortic Valve Implantation Still Effective in Nonagenarians?

The Israel Medical Association journal : IMAJ·2026
Same author

Medical evaluation of first presentation of psychotic symptoms in children and adolescents.

Frontiers in psychiatry·2026
Same author

Parkinson's disease in real life healthcare organization database: a medication-based algorithm.

BMC neurology·2026
Same author

Connectivity underlying motor cortex activity during goal-directed behaviour.

Nature·2025
Same author

Complementary Medicine for Treating Emotional Exhaustion and Burnout of Frontline Healthcare Providers during the COVID-19 Pandemic.

The Israel Medical Association journal : IMAJ·2025
Same author

Is it Possible To Identify Patients After Their First Hospitalization for a Psychotic Disorder Who Do Not Use Anti-Psychotics and are Not Later Rehospitalized?

Schizophrenia bulletin·2025

Related Experiment Video

Updated: Feb 10, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K

Pharmacologic prophylaxis against nerve agent poisoning.

Ido Layish1, Amir Krivoy, Eran Rotman

  • 1Chemical, Biological, Nuclear and Radiological Medicine Branch, Medical Corps, Israel Defense Force. Amitay2@zahav.net.il

The Israel Medical Association Journal : IMAJ
|March 29, 2005
PubMed
Summary

Nerve agent poisoning poses severe risks, but current pyridostigmine pretreatment offers limited central nervous system protection. New prophylactic strategies are needed to enhance protection against nerve agent toxicity.

More Related Videos

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

26.9K
Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
07:10

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Published on: March 7, 2011

19.2K

Related Experiment Videos

Last Updated: Feb 10, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.9K
Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

26.9K
Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
07:10

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Published on: March 7, 2011

19.2K

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Nerve agent poisoning causes rapid, severe symptoms including brain damage.
  • Pyridostigmine is a current military pretreatment but poorly crosses the blood-brain barrier, failing to protect the central nervous system.
  • There is a critical need for improved prophylactic strategies against nerve agents.

Purpose of the Study:

  • To review current limitations of nerve agent prophylaxis.
  • To explore alternative and novel prophylactic treatments for nerve agent poisoning.
  • To discuss potential therapeutic combinations and delivery methods.

Main Methods:

  • Literature review of nerve agent toxicity and current countermeasures.
  • Analysis of the pharmacokinetic limitations of pyridostigmine.
  • Exploration of alternative pharmacological targets and agents for prophylaxis.

Main Results:

  • Pyridostigmine provides inadequate protection against central nervous system effects of nerve agents.
  • Combinations of carbamates with central anticholinergics or NMDA receptor antagonists show promise.
  • Central acetylcholinesterase inhibitors and benzodiazepine receptor modulators are potential candidates.

Conclusions:

  • Pyridostigmine's limited efficacy necessitates the development of new prophylactic treatments.
  • Exploring novel combinations and central-acting agents is crucial for effective nerve agent protection.
  • Transdermal delivery and civilian applications warrant further investigation.